BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BIOCRATES Life Sciences GmbH Launches AbsoluteIDQ(TM) Kit for Metabolomics at Analytica in Munich


3/31/2008 2:54:29 PM

March 31, 2008, Innsbruck, Austria - BIOCRATES Life Sciences AG, a leading metabolomics company, is launching their AbsoluteIDQ Kit, an innovative breakthrough for quantitative metabolomics. BIOCRATES will be presenting the kit at Analytica 2008 in Munich, Germany, Hall A3, Stand 423.

The AbsoluteIDQ Kit is designed to be used with standard triple quadrupole mass spectrometers, allowing customers to keep their proprietary data in-house. Currently the AbsoluteIDQ Kit is optimized for Applied Biosystems API 4000™ and 4000 Q TRAP® LC/MS/MS Systems. The first kit version, p150, allows customers to accurately measure and identify more than a 150 metabolites in over 4 compound classes from their valuable clinical and pre-clinical plasma samples in just a few minutes per sample.

The kits will initially only be offered in Europe, but there are plans to expand distribution to the US and Asia. The MetIQ™ software package is an integral part of the AbsoluteIDQ Kit and provides a solution for the complete analytical process of targeted metabolomics, from project setup to calculation of metabolite concentrations. Future kits will include products with broader metabolite analysis as well as more focused kits for specific disease indications. Klaus Weinberger, CSO of BIOCRATES, stated, “We are excited to launch our robust, targeted metabolomics kits at Analytica 2008 in Munich. We have seen early interest in the kits from a number of companies and research institutes. We expect the kits to become a routine part of pre-clinical and clinical analysis in the future.”

Applications of the kit span from drug efficacy and toxicology to biomarker research & diagnostics and from fermentation optimisation to nutritional & functional food analysis. Some of the advantages of the AbsoluteIDQ Kit include:

Improved drug design and disease diagnosis by discovering and validating valuable markers of disease, drug efficacy, and toxicology

Early and accurate monitoring of efficacy and side effects of investigational or approved drugs; this means being able to halt development of non-efficacious drugs quickly and accelerate promising drug candidates to the market

Reduced costs for targeted metabolomics

Reduced sample volumes. The small volume needed gives labs the ability to move metabolomics to small-animal models and take multiple time points

The ability to obtain absolute concentrations of metabolites, not relative concentrations; this yields a reliable, repeatable, and robust platform for performing targeted metabolomics

In addition to selling metabolomic kits, BIOCRATES offers contract research services and works in collaboration with its partners to deliver the most trusted targeted metabolomics information in the industry. BIOCRATES has broad expertise in metabolomics method development, bioinformatics software and analytics, and data interpretation. Their TargetIDQ™ Services provide customers direct access to this expertise, enabling identification and quantification of hundreds of metabolites from a broad range of samples, ultimately revealing meaningful biomarkers. As part of BIOCRATES’ proprietary service offering, customers also gain access to outputs from their proprietary MarkerIDQ™ software. MarkerIDQ enables mass-spectrometry data to be mapped onto metabolic pathways, metabolomics measurements to be clearly displayed and visualized, and pathways to be represented graphically and dynamically, leading to improved data interpretation and study results. For more information about our kits and contract research services, please visit www.biocrates.com.

BIOCRATES Life Sciences AG Karoline Obitzhofer Innrain 66/II, A-6020 Innsbruck, Austria t: +43 512 579 823 4212 e: karoline.obitzhofer@biocrates.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES